New insulin affordability options from Novo now available in U.S.

Novo Nordisk (NVO +0.4%) launches its My$99Insulin Program, generic insulin brands and an Immediate Supply option for U.S. diabetes patients.

My$99Insulin provides up to three vials or two packs of FlexPen/FlexTouch/PenFill pens of any combination of Novo insulins.

Generic offerings and wholesale prices per package: Insulin Aspart vial ($144.68), Insulin Aspart PenFill cartridge – 5×3 mL ($268.73), Insulin Aspart FlexPen – 5×3 mL ($279.41), Insulin Aspart Mix 70/30 10 mL vial ($150.06) and Insulin Aspart 70/30 FlexPen – 5.3 mL ($279.41).

Potential for immediate shipment of up to three vials or two packs of pens at no-charge under Immediate Supply option for patients with a prescription.

Related tickers: Sanofi (SNY +0.7%), Eli Lilly (LLY -0.1%)

https://seekingalpha.com/news/3529132-new-insulin-affordability-options-from-novo-now-available-in-u-s